Biblio
2014
Baccelli I, Stenzinger A, Vogel V, Pfitzner BMaria, Klein C, Wallwiener M, Scharpff M, Saini M, Holland-Letz T, Sinn H-P, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014.
2016
Noll EM, Eisen C, Stenzinger A, Espinet E, Muckenhuber A, Klein C, Vogel V, Klaus B, Nadler W, Rösli C, et al. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nat Med. 2016.
]